This approval represents a significant regulatory milestone, making Prolivâ„¢Rx the first and only at-home neuromodulation ...
Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and Drug Administration (FDA) has approved ProlivtmRx, ...
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback